These final results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assist the strategy of targeting ACKR3 as a unique technique to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected Ailments. Be aware: Effects may https://leonarda062vmc7.wikicorrespondence.com/user